SCHEMBL20474255

SCHEMBL20474255

COC(=O)Cc1nc2cc(OC)ccc2cc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.47
ALDH1A1 P00352 7/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.47
CLK1 P49759 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
PLA2G2A P14555 5/20 0.44
HPGDS O60760 4/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17967333 0.90 SLC16A3 (0.48) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL635539 0.78 PTGS1 (0.52) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL24373427 0.78 KDM4E (0.57) KDM4EALDH1A1NPC1RAB9APLA2G2A
SCHEMBL7147155 0.75 ALDH1A1 (0.68) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL26882759 0.73 KDM4E (0.57) KDM4EALDH1A1HSD17B10CYP11B1CYP11B2
SCHEMBL9952903 0.73 KDM4E (0.54) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL21464329 0.73 KDM4E (0.51) KDM4EALDH1A1NPC1RAB9AHSD17B10
SCHEMBL19478133 0.71 DYRK1A (0.52) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL1574317 0.70 KDM4E (0.80) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL4741387 0.70 GPBAR1 (0.57) KDM4ENPC1PLA2G2AHPGDSCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF ABL1, FLT3, MAP3K7 KDM4E 892/4885ALDH1A1 1992/4885MAPT 2812/4885
US-10227355-B2 Quinoline derivatives and preparation thereof ABL1, FLT3, MAP3K7 KDM4E 939/4885ALDH1A1 2096/4885MAPT 2415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.